Danaher share price today

(DHR)

Danaher share price is $237.62 & ₹20,576.23 as on 15 Jan 2025, 2.30 'hrs' IST

$237.62

▲

-2.26

(-0.94%)

Market is closed - opens 8 PM, 15 Jan 2025

View live Danaher share price in Dollar and Rupees. Guide to invest in Danaher stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Danaher, along with analyst recommendations, forecasts, and comprehensive financials.

Danaher share price movements

Today's Low: $232.06
Today's High: $241.74
$237.62
2.34%
Downside
Day's Volatility :4.0%
Upside
1.7%
52 Weeks Low: $222.53
52 Weeks High: $281.70
$237.62
6.35%
Downside
52 Weeks Volatility :21.0%
Upside
15.65%

Danaher Returns

Period	Danaher Corp.	Sector (Health Care)	S&P500
3 Months	-10.5%	-7.5%	0.4%
6 Months	-4.53%	-4.3%	3.6%
1 Year	5.79%	0.7%	22.0%
3 Years	-16.82%	5.5%	25.2%

Danaher Key Statistics

in dollars & INR

Previous Close	$239.88
Open	$241.17
Today's High	$241.74
Today's Low	$232.06
Market Capitalization	$173.3B
Today's Volume	$3.2M
52 Week High	$281.7
52 Week Low	$222.53
Revenue TTM	$23.7B
EBITDA	$7.5B
Earnings Per Share (EPS)	$5.4
PE Ratio	44.42
Dividend Yield	0.46%
Profit Margin	16.39%
Quarterly Earnings Growth YOY	-0.26%
Return On Equity TTM	7.59%

How to invest in Danaher from India?

It is very easy for Indian residents to invest directly in Danaher from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Danaher stock in both Indian Rupees (INR) and US Dollars (USD). Search for Danaher or DHR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Danaher or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Danaher shares which would translate to 0.004 fractional shares of Danaher as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Danaher, in just a few clicks!

Returns in Danaher for Indian investors in Rupees

Investment Value

₹1,00,000

Danaher investment value today

Current value as on today

₹1,09,119

Returns

₹9,119

(+9.12%)

Returns from Danaher Stock

₹4,794 (+4.79%)

Dollar Returns

₹4,325 (+4.33%)

Indian investors sentiment towards Danaher

-59.18%

Period: Oct 16, 2024 to Jan 14, 2025. Change in 30 Days versus previous period

Investment in Danaher from India has reduced in the last 30 days as on Jan 15, 2025. -59.18% less purchase transactions for Danaher in the last 30 days versus the previous period.

17%

Period: Oct 16, 2024 to Jan 14, 2025. Change in 30 Days versus previous period

Search volume for Danaher on INDmoney from India has grown in the last 30 days as on Jan 15, 2025. 17% more investors are searching Danaher in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Danaher

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	5524	-148.87	0.30%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	935	0.00	1.23%

Global Institutional Holdings in Danaher

Vanguard Group Inc
8.23%
BlackRock Inc
6.89%
State Street Corp
3.80%
FMR Inc
3.27%
Wellington Management Company LLP
3.23%
T. Rowe Price Associates, Inc.
2.83%

Analyst Recommendation on Danaher

Buy

73%Buy

23%Hold

3%Sell

Based on 30 Wall street analysts offering stock ratings for Danaher(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Danaher

What analysts predicted

Upside of 19.7%

Target:

$284.43

Current:

$237.62

Insights on Danaher

Price Movement
In the last 7 days, DHR stock has moved up by 0.8%
Increasing Revenue
Danaher Corp. has shown consistent revenue growth over the past two quarters. In the latest quarter, the revenue increased from $5.74 billion to $5.79 billion. This reflects an average increase of 1.0% per quarter.
Decreasing Net Profit
Danaher Corp. has experienced a decline in net profit over the last three quarters, decreasing from $1.08 billion to $818 million. This represents an average drop of 13.2% in profit each quarter.
DHR vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 8.7% return, outperforming this stock by 2.2%
DHR vs A (3 yr)
In the last 3 years, Danaher Corp. has experienced a drawdown of -18.2%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 16.3%
Price to Sales
Danaher Corp. has a Price-to-Sales Ratio of 7.4, meaning investors are willing to pay $7.4 for every $1 of sales the company generates. In comparison, Agilent Technologies Inc. has a lower Price-to-Sales Ratio of 6.4, indicating that investors pay $6.4 for every $1 of sales. This suggests that Danaher Corp. is perceived as having stronger sales performance relative to Agilent Technologies.

Danaher Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$19.9B	↑ 8.53%
Net Income	$2.7B	↑ 6.37%
Net Profit Margin	13.33%	↓ 0.27%

	FY19	Y/Y Change
Revenue	$17.9B	↓ 9.96%
Net Income	$3.0B	↑ 13.48%
Net Profit Margin	16.8%	↑ 3.47%

	FY20	Y/Y Change
Revenue	$22.3B	↑ 24.41%
Net Income	$3.6B	↑ 21.2%
Net Profit Margin	16.36%	↓ 0.44%

	FY21	Y/Y Change
Revenue	$29.5B	↑ 32.17%
Net Income	$6.4B	↑ 76.44%
Net Profit Margin	21.84%	↑ 5.48%

	FY22	Y/Y Change
Revenue	$31.5B	↑ 6.85%
Net Income	$7.2B	↑ 12.06%
Net Profit Margin	22.91%	↑ 1.07%

	FY23	Y/Y Change
Revenue	$23.9B	↓ 24.09%
Net Income	$4.7B	↓ 34.21%
Net Profit Margin	19.85%	↓ 3.06%

	Q2 FY23	Q/Q Change
Revenue	$7.2B	↓ 0.14%
Net Income	$1.1B	↓ 23.72%
Net Profit Margin	15.45%	↓ 4.78%

	Q3 FY23	Q/Q Change
Revenue	$6.9B	↓ 3.97%
Net Income	$1.1B	↑ 2.08%
Net Profit Margin	16.43%	↑ 0.98%

	Q4 FY23	Q/Q Change
Revenue	$2.7B	↓ 60.82%
Net Income	$1.1B	↓ 4.43%
Net Profit Margin	40.07%	↑ 23.64%

	Q1 FY24	Q/Q Change
Revenue	$5.8B	↑ 115.22%
Net Income	$1.1B	↑ 0.83%
Net Profit Margin	18.77%	↓ 21.3%

	Q2 FY24	Q/Q Change
Revenue	$5.7B	↓ 0.91%
Net Income	$907.0M	↓ 16.64%
Net Profit Margin	15.79%	↓ 2.98%

	Q3 FY24	Q/Q Change
Revenue	$5.8B	↑ 0.96%
Net Income	$818.0M	↓ 9.81%
Net Profit Margin	14.11%	↓ 1.68%

	FY18	Y/Y Change
Profit	$11.1B	↑ 8.97%

	FY19	Y/Y Change
Profit	$10.0B	↓ 10.11%

	FY20	Y/Y Change
Profit	$12.5B	↑ 24.95%

	FY21	Y/Y Change
Profit	$18.0B	↑ 43.9%

	FY22	Y/Y Change
Profit	$18.9B	↑ 5.55%

	FY23	Y/Y Change
Profit	$14.0B	↓ 25.94%

	Q2 FY23	Q/Q Change
Profit	$4.0B	↓ 7.53%

	Q3 FY23	Q/Q Change
Profit	$4.0B	↓ 1.01%

	Q4 FY23	Q/Q Change
Profit	$1.6B	↓ 59.42%

	Q1 FY24	Q/Q Change
Profit	$3.5B	↑ 114.85%

	Q2 FY24	Q/Q Change
Profit	$3.4B	↓ 1.69%

	Q3 FY24	Q/Q Change
Profit	$3.4B	↓ 0.79%

	FY18	Y/Y Change
Operating Cash Flow	$4.0B	↑ 15.65%
Investing Cash Flow	$-2.9B	↑ 249.7%
Financing Cash Flow	$-797.0M	↓ 74.28%

	FY19	Y/Y Change
Operating Cash Flow	$4.0B	↓ 1.75%
Investing Cash Flow	$-1.2B	↓ 58.02%
Financing Cash Flow	$16.4B	↓ 2153.44%

	FY20	Y/Y Change
Operating Cash Flow	$6.2B	↑ 57.1%
Investing Cash Flow	$-21.2B	↑ 1615.45%
Financing Cash Flow	$1.0B	↓ 93.85%

	FY21	Y/Y Change
Operating Cash Flow	$8.4B	↑ 34.63%
Investing Cash Flow	$-13.0B	↓ 38.85%
Financing Cash Flow	$1.3B	↑ 28.73%

	FY22	Y/Y Change
Operating Cash Flow	$8.5B	↑ 1.93%
Investing Cash Flow	$-2.2B	↓ 82.8%
Financing Cash Flow	$-2.6B	↓ 298.46%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$1.9B	↓ 1.08%
Investing Cash Flow	$-431.0M	↑ 41.78%
Financing Cash Flow	$-208.0M	↓ 20.61%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.7B	↓ 13.19%
Investing Cash Flow	$-1.1B	↑ 146.87%
Financing Cash Flow	$2.4B	↓ 1274.52%

Danaher Technicals Summary

Sell

Neutral

Buy

Danaher is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Danaher Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Danaher Corp.	2.43%	-4.53%	5.79%	-16.82%	47.11%
Agilent Technologies Inc.	3.11%	6.33%	8.75%	1.05%	57.51%
Idexx Laboratories, Inc.	-1.82%	-14.88%	-18.73%	-18.44%	47.87%
Thermo Fisher Scientific, Inc.	4.76%	0.08%	2.49%	-5.86%	63.78%
Iqvia Holdings Inc.	3.83%	-11.14%	-3.79%	-15.55%	26.7%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Danaher Corp.	44.42	44.42	3.2	7.5	0.08	0.04	0.0	71.03
Agilent Technologies Inc.	31.06	31.06	2.33	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	40.33	40.33	4.4	10.73	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	34.02	34.02	2.14	21.69	0.13	0.05	0.0	128.08
Iqvia Holdings Inc.	26.75	26.75	1.07	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Danaher Corp.	Buy	$173.3B	47.11%	44.42	16.39%
Agilent Technologies Inc.	Buy	$40.5B	57.51%	31.06	21.75%
Idexx Laboratories, Inc.	Buy	$34.6B	47.87%	40.33	22.53%
Thermo Fisher Scientific, Inc.	Buy	$212.5B	63.78%	34.02	14.48%
Iqvia Holdings Inc.	Buy	$37.1B	26.7%	26.75	9.17%

Danaher Dividend announcements

Danaher Dividends December, 2024
In the quarter ending December,2024. Danaher has declared dividend of $0.27
Read More

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Organization	Danaher
Employees	61000
CEO	Mr. Steven M. Rales
Industry	Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Management People of Danaher

Name	Title
Mr. Steven M. Rales	Co-Founder & Chairman
Mr. Rainer M. Blair	President, CEO & Director
Mr. Mitchell P. Rales	Co-Founder & Director
Mr. Matthew R. McGrew	CFO & Executive VP
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Senior VP & Chief Science Officer
Ms. Georgeann F. Couchara	Senior Vice President of Human Resources
Mr. Christopher M. Bouda	VP & Chief Accounting Officer
Mr. John Bedford	Vice President of Investor Relations
Mr. Brian W. Ellis J.D.	Senior VP, General Counsel & Chief Compliance Officer
Mr. Daniel A. Raskas J.D.	Senior Vice President of Corporate Development

Important FAQs about investing in Danaher from India :

What is Danaher share price today?

Danaher share price today stands at $237.62, Open: $241.17 ; Previous Close: $239.88 ; High: $241.74 ; Low: $232.06 ; 52 Week High: $281.70 ; 52 Week Low: $222.53. The stock opens at $241.17, after a previous close of $239.88. The stock reached a daily high of $241.74 and a low of $232.06, with a 52-week high of $281.70 and a 52-week low of $222.53.

Can Indians buy Danaher shares?

Yes, Indians can invest in the Danaher (DHR) from India.

With INDmoney, you can buy Danaher at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Danaher at zero transaction cost.

How can I buy Danaher shares from India?

It is very easy to buy Danaher from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Danaher be purchased?

Yes, you can buy fractional shares of Danaher with INDmoney app.

What are the documents required to start investing in Danaher stocks?

To start investing in Danaher, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.